
Actinium Pharmaceuticals ATNM
€ 1.06
-3.52%
Geschäftsbericht 2025
hinzugefügt 30.03.2026
Actinium Pharmaceuticals P/B 2011-2026 | ATNM
P/B Jährlich Actinium Pharmaceuticals
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 3.94 | 1.48 | 5.73 | 3.39 | 1.51 | 1.46 | 6.77 | 6.74 | 3.48 | 2.74 | 3.68 | -76.7 | -83.2 | 1.44 | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 6.77 | -83.2 | -8.39 |
P/B anderer Aktien in der Pharmaeinzelhändler
| Name | P/B | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
MorphoSys AG
MOR
|
1.28 | - | 2.43 % | $ 254 M | ||
|
Amphastar Pharmaceuticals
AMPH
|
1.58 | $ 21.81 | 1.87 % | $ 1.02 B | ||
|
I-Mab
IMAB
|
1.12 | - | - | $ 866 M | ||
|
Aeglea BioTherapeutics
AGLE
|
1.4 | - | - | $ 1.01 B | ||
|
Midatech Pharma plc
MTP
|
7.56 | - | -18.52 % | $ 27.3 M | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
2.88 | - | - | $ 40.3 B | ||
|
Aptorum Group Limited
APM
|
0.485 | $ 0.91 | 1.61 % | $ 6.69 M | ||
|
Biophytis SA
BPTS
|
15.7 | - | -13.47 % | $ 169 M | ||
|
Genfit SA
GNFT
|
596 | - | 2.54 % | $ 160 B | ||
|
ACADIA Pharmaceuticals
ACAD
|
4.36 | $ 22.56 | 2.73 % | $ 3.74 B | ||
|
EyeGate Pharmaceuticals, Inc.
EYEG
|
4.13 | - | -1.52 % | $ 24.7 M | ||
|
Esperion Therapeutics
ESPR
|
-1.86 | $ 1.97 | 3.14 % | $ 409 M | ||
|
Advaxis
ADXS
|
0.113 | - | -9.65 % | $ 45.9 M | ||
|
AIkido Pharma
AIKI
|
0.492 | - | 1.93 % | $ 17.4 M | ||
|
Galectin Therapeutics
GALT
|
-1.41 | $ 2.43 | 4.29 % | $ 155 M | ||
|
Greenwich LifeSciences
GLSI
|
45.4 | $ 24.22 | 0.04 % | $ 315 M | ||
|
Akouos
AKUS
|
0.736 | - | 0.23 % | $ 488 M | ||
|
Heron Therapeutics
HRTX
|
13.8 | $ 1.21 | 1.26 % | $ 202 M | ||
|
ImmuCell Corporation
ICCC
|
2.15 | $ 8.22 | -1.56 % | $ 74.2 M | ||
|
Allakos
ALLK
|
0.674 | - | - | $ 28.6 M | ||
|
InflaRx N.V.
IFRX
|
1.41 | $ 1.61 | 8.78 % | $ 152 M | ||
|
AlloVir
ALVR
|
-0.258 | - | 4.14 % | $ 49.1 M | ||
|
Ampio Pharmaceuticals
AMPE
|
0.198 | - | -11.43 % | $ 502 K | ||
|
Институт стволовых клеток человека
ISKJ
|
6.81 | - | - | - | ||
|
Applied Molecular Transport
AMTI
|
0.364 | - | - | $ 10.1 M | ||
|
Innate Pharma S.A.
IPHA
|
1.36 | $ 1.4 | -1.06 % | $ 235 M | ||
|
Aeterna Zentaris
AEZS
|
0.781 | - | 5.93 % | $ 314 M | ||
|
Brainstorm Cell Therapeutics
BCLI
|
-0.815 | - | -2.5 % | $ 5.88 M | ||
|
Applied Therapeutics
APLT
|
-31.5 | - | - | $ 8.42 M | ||
|
Aptinyx
APTX
|
0.248 | - | -39.0 % | $ 4.57 M | ||
|
AgeX Therapeutics
AGE
|
0.00262 | - | -10.17 % | $ 12.2 K | ||
|
Aravive
ARAV
|
5.67 | - | -13.39 % | $ 1.45 M | ||
|
Inventiva S.A.
IVA
|
6.02 | $ 5.07 | -1.65 % | $ 138 M | ||
|
Jaguar Health
JAGX
|
-0.0512 | $ 0.34 | -13.72 % | $ 793 K | ||
|
Aridis Pharmaceuticals
ARDS
|
-0.17 | - | 17.91 % | $ 11.1 M | ||
|
BioNTech SE
BNTX
|
5.29 | $ 102.66 | -2.66 % | $ 27.2 B | ||
|
Avenue Therapeutics
ATXI
|
0.293 | - | -52.27 % | $ 4.45 M | ||
|
Applied Genetic Technologies Corporation
AGTC
|
0.382 | - | - | $ 26.5 M | ||
|
KalVista Pharmaceuticals
KALV
|
-308 | $ 19.68 | 0.25 % | $ 1.06 B | ||
|
Aquestive Therapeutics
AQST
|
-13.9 | $ 4.12 | 0.86 % | $ 441 M | ||
|
Arcutis Biotherapeutics
ARQT
|
18.2 | $ 23.45 | 0.82 % | $ 2.98 B | ||
|
Ayala Pharmaceuticals
AYLA
|
0.994 | - | - | $ 7.46 M | ||
|
Autolus Therapeutics plc
AUTL
|
1.81 | $ 1.44 | -0.35 % | $ 383 M | ||
|
Aptose Biosciences
APTO
|
-0.511 | - | -45.71 % | $ 1.2 M | ||
|
AstraZeneca PLC
AZN
|
2.07 | - | - | $ 96.9 B | ||
|
Ligand Pharmaceuticals Incorporated
LGND
|
2.67 | $ 232.91 | 0.71 % | $ 4.26 B | ||
|
AVROBIO
AVRO
|
0.594 | - | 1083.1 % | $ 745 M | ||
|
Eli Lilly and Company
LLY
|
8.36 | $ 880.24 | -0.42 % | $ 790 B | ||
|
Can-Fite BioPharma Ltd.
CANF
|
32 | $ 2.92 | -0.34 % | $ 4.81 M | ||
|
BioDelivery Sciences International
BDSI
|
1.64 | - | -4.8 % | $ 255 M |